Soft Tissue Neoplasms clinical trials
The registry lists 38 studies for Soft Tissue Neoplasms across more than 10 countries. 14 are recruiting or about to start. 17 of them are mainly about Soft Tissue Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.
Get an email when these change. Save the Soft Tissue Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Alpha Tau Medical LTD. (5) · Istituto Ortopedico Rizzoli (3) · Central Hospital, Nancy, France (2) · Mayo Clinic (2) · Assiut University (2) · Cogent Biosciences, Inc. (1) · University of California, San Francisco (1) · Wuxi No. 4 People's Hospital (1)
What is being tested here
Drugs under test in Soft Tissue Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Bezuclastinib | 1 | 0 | 1 |
| Iparomlimab/Tuvonralimab | 1 | 0 | 1 |
| Binimetinib | 0 | 0 | 1 |
| Trabectedin | 0 | 0 | 1 |
| Bevacizumab | 0 | 0 | 1 |
| Temsirolimus | 0 | 0 | 1 |
| Liposomal Bupivacaine | 0 | 0 | 1 |
| Bupivacaine | 0 | 0 | 1 |
| Aspirin | 0 | 0 | 1 |
| Enoxaparin | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Dec 2026Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) · Alpha Tau Medical LTD.
- Dec 2026Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer · Istanbul University
- Jan 2027Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia · Alpha Tau Medical LTD.
- May 2027QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma · Sun Yat-sen University
Who these studies take
Of the 11 Soft Tissue Neoplasms studies recruiting now, 7 (64%) set no upper age limit and 1 (9%) stop at 75 or younger. 4 (36%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 4 (36%) | 4 (36%) |
| 18 | 11 (100%) | 11 (100%) |
| 30 | 11 (100%) | 11 (100%) |
| 40 | 11 (100%) | 11 (100%) |
| 50 | 11 (100%) | 11 (100%) |
| 65 | 11 (100%) | 11 (100%) |
| 75 | 11 (100%) | 11 (100%) |
| 85 | 10 (91%) | 10 (91%) |
Across all 38 studies, recruiting or not: 21% stop at 75 or younger and 16% at 65; 47% take children; 0% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Studies
Recruiting first, then most recently updated. Showing 38 of 38. search them.
- Prospective Registry of Histotripsy for Soft Tissue TumorsEnrolling by invitationNCT074700081 country
- Molecular and Clinical Studies of Bone and Soft Tissue TumorsRecruitingNCT078222041 country
- (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisRecruitingNCT04996875Phase 214 countries
- Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue TumorsRecruitingNCT07062003Not applicable1 country
- Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue CancerRecruitingNCT077274341 country
- Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer HospitalNot yet recruitingNCT07606287Not applicable1 country
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaRecruitingNCT04534127Not applicable1 country
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.RecruitingNCT03889899Not applicable1 country
- QL1706 in the Treatment of Advanced Bone and Soft Tissue SarcomaRecruitingNCT06939855Phase 21 country
- Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma TherapyRecruitingNCT065999571 country
- Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid TumorsRecruitingNCT071129891 country
- Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue TumorsNot yet recruitingNCT069791151 country
- Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue TumorsRecruitingNCT054689701 country
- Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors IIRecruitingNCT043940521 country
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 11 country
- Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)Active, not recruitingNCT03737734Not applicable1 country
- Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)TerminatedNCT03886181Not applicable1 country
- Retreatment With Intratumoral Diffusing Alpha Radiation EmittersCompletedNCT04540588Not applicable1 country
- Study of MEK162 for Children With Low-Grade GliomasCompletedNCT02285439Phase 1/21 country
- US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue TumorsCompletedNCT034526441 country
- An Adequate Cost Effective Follow Up Protocol For Bone and Soft Tissue SarcomasCompletedNCT058274581 country
- Liposomal Bupivacaine (Exparel) in SarcomasTerminatedNCT03867188Early Phase 11 country
- Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper EgyptCompletedNCT043001791 country
- An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized TrialCompletedNCT003847351 country
- To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid TumorsCompletedNCT03159585Phase 11 country
- Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective StudyCompletedNCT025572431 country
- A New Method: the Third Space Robotic and Endoscopic Cooperative Surgery (TS-RECS)CompletedNCT03804762Not applicable1 country
- National Swiss Sarcoma Cohort StudyTerminatedNCT027757991 country
- Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue TumorsTerminatedNCT01965002Not applicable1 country
- Trabectedin First Line Therapy In Unfit Sarcoma StudyCompletedNCT02066675Phase 21 country
- Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) PatientsCompletedNCT012764831 country
- Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer DiagnosticsStatus unknownNCT02441972Phase 11 country
- Osteoarticular Tumor Characterization by Advanced ImagingStatus unknownNCT02895633Not applicable1 country
- Magnetic Resonance Imaging or Ultrasound in Soft Tissue Tumors (MUSTT)Status unknownNCT028345851 country
- Quantitative MR Biomarkers for Sarcoma TreatmentCompletedNCT01017978Not applicable1 country
- MR-Guided Laser Ablation of Hepatic TumorsCompletedNCT01630239Early Phase 11 country
- Radiofrequency Ablation of Painful Soft Tissue NeoplasmsCompletedNCT000418861 country
- Clinical Outcome of Pediatric Dermatofibrosarcoma ProtuberansStatus unknownNCT001733551 country